How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | BASABASANITE, INC. | CMTCORE MOLDING TECHNOLOGIES INC | KBLBKraig Biocraft Laboratories, Inc. | ITX.LITX.L | Median of the restexcluding BASA |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $0.0201▼ 0.00 (12.61%) | $23.54▲ 0.98 (4.34%) | $0.081▲ 0.00 (1.25%) | £180.00▼ 2.00 (1.10%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 2.0/10 | 7.0/10 | 2.0/10 | 4.7/10 | 4.7/10 |
| Market value | $5.2M | $200.3M | $84.5M | $2.43B | |
| Revenue | — | $273.8M | — | $7.8M | |
| Profit | -$1.7M | $11.2M | -$3.6M | -$1.0M | |
| Revenue growthChange in sales versus the prior year. | — | -9.5% | — | 61.4% | 26.0% |
| Gross marginShare of sales left after the direct cost of producing them. | — | 17.4% | — | 34.7% | 26.0% |
| Operating marginShare of sales left after running the business, before interest and tax. | — | 5.2% | — | -9.9% | -2.4% |
| Profit marginProfit kept from each dollar of sales. | — | 4.1% | — | -13.1% | -4.5% |
| Free cash flow marginCash left after capital spending, as a share of sales. | — | 0.7% | — | -19.6% | -9.5% |
| Return on equityProfit against the owners' stake in the company. | 19.6% | 7.1% | 45.3% | -16.8% | 7.1% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | — | 7.8% | — | -14.0% | -3.1% |
| P/E ratioPrice paid per dollar of annual profit. | — | 17.90x | — | — | 17.90x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | 6.85x | — | — | 6.85x |
| Price to book | -0.59x | 1.27x | -10.56x | 394.34x | 1.27x |
| Debt to equityTotal liabilities compared with owners' stake. | -1.03x | 0.44x | -1.32x | 0.57x | 0.44x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 3/6 | 6/9 | 3/6 | 4/8 | 4.0 |
| Bankruptcy riskAltman Z-Score zone. | not reported | safe | not reported | distress |
How BASA compares with the others
- Its liabilities are lower relative to equity than the median of the other companies selected: -1.0x against 0.4x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.